Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.059
Filter
1.
Open Biol ; 14(5): 230315, 2024 May.
Article in English | MEDLINE | ID: mdl-38806144

ABSTRACT

Candida glabrata is an important pathogen causing invasive infection associated with a high mortality rate. One mechanism that causes the failure of Candida eradication is an increase in regulatory T cells (Treg), which play a major role in immune suppression and promoting Candida pathogenicity. To date, how C. glabrata induces a Treg response remains unclear. Dendritic cells (DCs) recognition of fungi provides the fundamental signal determining the fate of the T-cell response. This study investigated the interplay between C. glabrata and DCs and its effect on Treg induction. We found that C. glabrata ß-glucan was a major component that interacted with DCs and consequently mediated the Treg response. Blocking the binding of C. glabrata ß-glucan to dectin-1 and complement receptor 3 (CR3) showed that CR3 activation in DCs was crucial for the induction of Treg. Furthermore, a ligand-receptor binding assay showed the preferential binding of C. glabrata ß-glucan to CR3. Our data suggest that C. glabrata ß-glucan potentially mediates the Treg response, probably through CR3-dependent activation in DCs. This study contributes new insights into immune modulation by C. glabrata that may lead to a better design of novel immunotherapeutic strategies for invasive C. glabrata infection.


Subject(s)
Candida glabrata , Dendritic Cells , Macrophage-1 Antigen , T-Lymphocytes, Regulatory , beta-Glucans , Candida glabrata/metabolism , Candida glabrata/pathogenicity , Dendritic Cells/immunology , Dendritic Cells/metabolism , Dendritic Cells/drug effects , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , beta-Glucans/metabolism , beta-Glucans/pharmacology , Animals , Macrophage-1 Antigen/metabolism , Mice , Lectins, C-Type/metabolism , Candidiasis/immunology , Candidiasis/microbiology , Candidiasis/metabolism , Mice, Inbred C57BL
2.
Int J Med Mushrooms ; 26(6): 13-23, 2024.
Article in English | MEDLINE | ID: mdl-38801085

ABSTRACT

Brazil-grown outdoor-cultivated Agaricus brasiliensis KA21 fruiting body (KA21) significantly increases the production of serum anti-beta-glucan antibody. Therefore, KA21 ingestion may be useful for the prevention and alleviation of fungal infections. This study aimed to determine the effects of KA21 in fungal infections in animals. KA21 was administered to nine dogs infected with Malassezia. Notably, the anti-beta-glucan antibody titer remained unchanged or tended to decrease in the oral steroid arm, whereas in the non-steroid arm, antibody titer increased in almost all animals after KA21 ingestion. Dogs showing improved clinical symptoms exhibited increased anti-beta-glucan antibody titers. The results of this study suggest that KA21 ingestion may alleviate the symptoms of Malassezia and other fungal infections and that continuous ingestion may help prolong recurrence-free intervals. Additionally, the ingestion of KA21 during oral steroid dosage reduction or discontinuation may enable smoother steroid withdrawal.


Subject(s)
Agaricus , Dog Diseases , Fruiting Bodies, Fungal , Malassezia , Animals , Dogs , Agaricus/chemistry , Fruiting Bodies, Fungal/chemistry , Malassezia/drug effects , Dog Diseases/microbiology , Dog Diseases/drug therapy , Dermatomycoses/veterinary , Dermatomycoses/prevention & control , Dermatomycoses/drug therapy , Dermatomycoses/microbiology , beta-Glucans/administration & dosage , beta-Glucans/pharmacology , Male , Brazil , Dermatitis/drug therapy , Dermatitis/veterinary , Dermatitis/microbiology , Dermatitis/prevention & control , Female , Antibodies, Fungal/blood
3.
J Immunol Res ; 2024: 2765001, 2024.
Article in English | MEDLINE | ID: mdl-38774603

ABSTRACT

ß-Glucan is the main component of the cell wall of pathogen-associated molecular patterns (PAMPs) including various yeast, fungi, or certain bacteria. Previous reports demonstrated that ß-glucan was widely investigated as a potent immunomodulators to stimulate innate and adaptive immune responses, which indicated that it could be recommended as an effective adjuvant in immunotherapy. However, the detailed effects of ß-glucan on neonatal immunity are still largely unknown. Here, we found that ß-glucan did not affect the frequencies and numbers of myeloid cells in the spleen and bone marrow from neonates. Functional assay revealed that ß-glucan from neonates compromised the immunosuppressive function of immature myeloid cells, which were myeloid-derived suppressor cells (MDSCs). Flow cytometry or gene expression analysis revealed that ß-glucan-derived polymorphonuclear (PMN)-MDSCs produced lower level of reactive oxygen species (ROS) and arginase-1 (Arg1) in neonatal mice. Furthermore, ß-glucan administration significantly decreased the frequency and ROS level of PMN-MDSCs in vitro. These observations suggest that ß-glucan facilitates the maturation of myeloid cells in early life, which may contribute to its beneficial effects against immune disorders later in life.


Subject(s)
Animals, Newborn , Arginase , Myeloid-Derived Suppressor Cells , Reactive Oxygen Species , beta-Glucans , beta-Glucans/pharmacology , Animals , Mice , Reactive Oxygen Species/metabolism , Myeloid-Derived Suppressor Cells/immunology , Myeloid-Derived Suppressor Cells/metabolism , Myeloid-Derived Suppressor Cells/drug effects , Arginase/metabolism , Myeloid Cells/metabolism , Myeloid Cells/immunology , Myeloid Cells/drug effects , Spleen/immunology , Spleen/metabolism , Spleen/cytology , Humans , Neutrophils/immunology , Neutrophils/metabolism , Neutrophils/drug effects , Mice, Inbred C57BL
4.
Molecules ; 29(9)2024 Apr 26.
Article in English | MEDLINE | ID: mdl-38731488

ABSTRACT

This study synthesized a novel oat ß-glucan (OBG)-Cr(III) complex (OBG-Cr(III)) and explored its structure, inhibitory effects on α-amylase and α-glucosidase, and hypoglycemic activities and mechanism in vitro using an insulin-resistant HepG2 (IR-HepG2) cell model. The Cr(III) content in the complex was found to be 10.87%. The molecular weight of OBG-Cr(III) was determined to be 7.736 × 104 Da with chromium ions binding to the hydroxyl groups of OBG. This binding resulted in the increased asymmetry and altered spatial conformation of the complex along with significant changes in morphology and crystallinity. Our findings demonstrated that OBG-Cr(III) exhibited inhibitory effects on α-amylase and α-glucosidase. Furthermore, OBG-Cr(III) enhanced the insulin sensitivity of IR-HepG2 cells, promoting glucose uptake and metabolism more efficiently than OBG alone. The underlying mechanism of its hypoglycemic effect involved the modulation of the c-Cbl/PI3K/AKT/GLUT4 signaling pathway, as revealed by Western blot analysis. This research not only broadened the applications of OBG but also positioned OBG-Cr(III) as a promising Cr(III) supplement with enhanced hypoglycemic benefits.


Subject(s)
Chromium , Hypoglycemic Agents , alpha-Glucosidases , beta-Glucans , Humans , Chromium/chemistry , Chromium/pharmacology , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/chemical synthesis , beta-Glucans/chemistry , beta-Glucans/pharmacology , Hep G2 Cells , alpha-Glucosidases/metabolism , alpha-Amylases/antagonists & inhibitors , alpha-Amylases/metabolism , Insulin Resistance , Glucose/metabolism , Signal Transduction/drug effects , Glucose Transporter Type 4/metabolism , Avena/chemistry , Glycoside Hydrolase Inhibitors/pharmacology , Glycoside Hydrolase Inhibitors/chemistry , Coordination Complexes/chemistry , Coordination Complexes/pharmacology , Coordination Complexes/chemical synthesis
5.
Molecules ; 29(9)2024 May 02.
Article in English | MEDLINE | ID: mdl-38731604

ABSTRACT

Edible grey oyster mushroom, Pleurotus sajor-caju, ß (1,3), (1,6) glucan possesses a wide range of biological activities, including anti-inflammation, anti-microorganism and antioxidant. However, its biological activity is limited by low water solubility resulting from its high molecular weight. Our previous study demonstrated that enzymatic hydrolysis of grey oyster mushroom ß-glucan using Hevea ß-1,3-glucanase isozymes obtains a lower molecular weight and higher water solubility, Pleurotus sajor-caju glucanoligosaccharide (Ps-GOS). Additionally, Ps-GOS potentially reduces osteoporosis by enhancing osteoblast-bone formation, whereas its effect on osteoclast-bone resorption remains unknown. Therefore, our study investigated the modulatory activities and underlying mechanism of Ps-GOS on Receptor activator of nuclear factor kappa-Β ligand (RANKL) -induced osteoclastogenesis in pre-osteoclastic RAW 264.7 cells. Cell cytotoxicity of Ps-GOS on RAW 264.7 cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay and its effect on osteoclast differentiation was determined by tartrate-resistant acid phosphatase (TRAP) staining. Additionally, its effect on osteoclast bone-resorptive ability was detected by pit formation assay. The osteoclastogenic-related factors were assessed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR), Western blot and immunofluorescence. The results revealed that Ps-GOS was non-toxic and significantly suppressed the formation of mature osteoclast multinucleated cells and their resorption activity by reducing the number of TRAP-positive cells and pit formation areas in a dose-dependent manner. Additionally, Ps-GOS attenuated the nuclear factor kappa light chain-enhancer of activated B cells' P65 (NFκB-P65) expression and their subsequent master osteoclast modulators, including nuclear factor of activated T cell c1 (NFATc1) and Fos proto-oncogene (cFOS) via the NF-κB pathway. Furthermore, Ps-GOS markedly inhibited RANK expression, which serves as an initial transmitter of many osteoclastogenesis-related cascades and inhibited proteolytic enzymes, including TRAP, matrix metallopeptidase 9 (MMP-9) and cathepsin K (CTK). These findings indicate that Ps-GOS could potentially be beneficial as an effective natural agent for bone metabolic disease.


Subject(s)
Cell Differentiation , NF-kappa B , NFATC Transcription Factors , Osteoclasts , Pleurotus , RANK Ligand , Receptor Activator of Nuclear Factor-kappa B , Signal Transduction , Animals , Mice , Osteoclasts/drug effects , Osteoclasts/metabolism , Osteoclasts/cytology , RAW 264.7 Cells , RANK Ligand/metabolism , Cell Differentiation/drug effects , Signal Transduction/drug effects , NF-kappa B/metabolism , Pleurotus/chemistry , Receptor Activator of Nuclear Factor-kappa B/metabolism , NFATC Transcription Factors/metabolism , Proto-Oncogene Proteins c-fos/metabolism , beta-Glucans/pharmacology , beta-Glucans/chemistry , Oligosaccharides/pharmacology , Oligosaccharides/chemistry , Osteogenesis/drug effects
6.
Int J Mol Sci ; 25(9)2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38731838

ABSTRACT

The effect of dietary supplementation with sodium butyrate, ß-glucan and vitamins (A, D3, E, K, C) on breeding indicators and immune parameters of juvenile African catfish was examined. The fish were fed with unenriched (group C) and enriched feed with a variable proportion of sodium butyrate/ß-glucan, and constant content of vitamins (W1-W3). After the experiment, blood and the middle gut were collected. The microbiome of the gut was determined using Next Generation Sequencing (NGS). Liver tissue was collected for determination of expression of immune-related genes (HSP70, IL-1ß, TNFα). W2 and W3 were characterized by the most favorable values of breeding indicators (p < 0.05). The highest blood cortisol concentration was in group C (71.25 ± 10.45 ng/mL), and significantly the lowest in W1 (46.03 ± 7.01 ng/ mL) (p < 0.05). The dominance of Cetobacterium was observed in all study groups, with the largest share in W3 (65.25%) and W1 (61.44%). Gene expression showed an increased number of HSP70 genes in W1. IL-1ß and TNFα genes peaked at W3. The W3 variant turns out to be the most beneficial supplementation, due to the improvement of breeding and immunological parameters. The data obtained can be used to create a preparation for commercial use in the breeding of this species.


Subject(s)
Butyric Acid , Catfishes , Dietary Supplements , Gastrointestinal Microbiome , Hydrocortisone , Vitamins , beta-Glucans , Animals , beta-Glucans/pharmacology , beta-Glucans/administration & dosage , Gastrointestinal Microbiome/drug effects , Butyric Acid/pharmacology , Catfishes/immunology , Catfishes/genetics , Catfishes/microbiology , Hydrocortisone/blood , Vitamins/pharmacology , Vitamins/administration & dosage , Animal Feed , HSP70 Heat-Shock Proteins/genetics , Interleukin-1beta/genetics , Interleukin-1beta/metabolism
7.
Int J Mol Sci ; 25(9)2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38731854

ABSTRACT

Factors that reduce the risk of developing colorectal cancer include biologically active substances. In our previous research, we demonstrated the anti-inflammatory, immunomodulatory, and antioxidant effects of oat beta-glucans in gastrointestinal disease models. The aim of this study was to investigate the effect of an 8-week consumption of a diet supplemented with low-molar-mass oat beta-glucan in two doses on the antioxidant potential, inflammatory parameters, and colonic metabolomic profile in azoxymethane(AOM)-induced early-stage colorectal cancer in the large intestine wall of rats. The results showed a statistically significant effect of AOM leading to the development of neoplastic changes in the colon. Consumption of beta-glucans induced changes in colonic antioxidant potential parameters, including an increase in total antioxidant status, a decrease in the superoxide dismutase (SOD) activity, and a reduction in thiobarbituric acid reactive substance (TBARS) concentration. In addition, beta-glucans decreased the levels of pro-inflammatory interleukins (IL-1α, IL-1ß, IL-12) and C-reactive protein (CRP) while increasing the concentration of IL-10. Metabolomic studies confirmed the efficacy of oat beta-glucans in the AOM-induced early-stage colon cancer model by increasing the levels of metabolites involved in metabolic pathways, such as amino acids, purine, biotin, and folate. In conclusion, these results suggest a wide range of mechanisms involved in altering colonic metabolism during the early stage of carcinogenesis and a strong influence of low-molar-mass oat beta-glucan, administered as dietary supplement, in modulating these mechanisms.


Subject(s)
Antioxidants , Azoxymethane , Colorectal Neoplasms , beta-Glucans , Animals , beta-Glucans/pharmacology , Azoxymethane/toxicity , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/chemically induced , Colorectal Neoplasms/pathology , Rats , Male , Antioxidants/pharmacology , Antioxidants/metabolism , Disease Models, Animal , Avena/chemistry , Superoxide Dismutase/metabolism , Colon/metabolism , Colon/pathology , Colon/drug effects , Oxidative Stress/drug effects , Rats, Wistar , C-Reactive Protein/metabolism
8.
Nutrients ; 16(9)2024 Apr 28.
Article in English | MEDLINE | ID: mdl-38732570

ABSTRACT

Black trumpet (Craterellus cornucopioides) is a mushroom present in many countries but underestimated. The aim of this publication is to present the latest state of knowledge about the chemical composition and bioactivity of C. cornucopioides and the possibility of its application in food. According to researchers, black trumpet is very rich in nutritional compounds, including unsaturated fatty acids (mainly oleic and linoleic acids), ß-glucans, minerals, and vitamins as well as polyphenols and tannins. It also contains compounds influencing the sensory properties, like free amino acids and nucleotides as well as sugars and polyols, mainly mannitol. Many of the described components show high nutritional and bioactive properties. Therefore, C. cornucopioides shows antioxidant activity and immunostimulating, anti-inflammatory, and anticancer effects as well as antibacterial, antifungal, antiviral, and antihyperglycemic effects. This makes black trumpet, also called horn of plenty, a mushroom with great potential for use both in medicine and directly in food. So far, black trumpet is not widely used in food, especially processed food. There are only a few studies on the use of dried black trumpet in sausages, but there is great potential for its use in food.


Subject(s)
Nutritive Value , Humans , Antioxidants/pharmacology , Agaricales/chemistry , Health Promotion/methods , Polyphenols/analysis , Polyphenols/pharmacology , beta-Glucans/pharmacology , Functional Food
9.
Nutrients ; 16(8)2024 Apr 11.
Article in English | MEDLINE | ID: mdl-38674816

ABSTRACT

Colorectal cancer (CRC) accounts for 30% of all cancer cases worldwide and is the second leading cause of cancer-related deaths. CRC develops over a long period of time, and in the early stages, pathological changes can be mitigated through nutritional interventions using bioactive plant compounds. Our study aims to determine the effect of highly purified oat beta-glucan on an animal CRC model. The study was performed on forty-five male Sprague-Dawley rats with azoxymethane-induced early-stage CRC, which consumed feed containing 1% or 3% low molar mass oat beta-glucan (OBG) for 8 weeks. In the large intestine, morphological changes, CRC signaling pathway genes (RT-PCR), and proteins (Western blot, immunohistochemistry) expression were analyzed. Whole blood hematology and blood redox status were also performed. Results indicated that the histologically confirmed CRC condition led to a downregulation of the WNT/ß-catenin pathway, along with alterations in oncogenic and tumor suppressor gene expression. However, OBG significantly modulated these effects, with the 3% OBG showing a more pronounced impact. Furthermore, CRC rats exhibited elevated levels of oxidative stress and antioxidant enzyme activity in the blood, along with decreased white blood cell and lymphocyte counts. Consumption of OBG at any dose normalized these parameters. The minimal effect of OBG in the physiological intestine and the high activity in the pathological condition suggest that OBG is both safe and effective in early-stage CRC.


Subject(s)
Avena , Dietary Supplements , Oxidative Stress , Rats, Sprague-Dawley , beta-Glucans , Animals , Male , beta-Glucans/pharmacology , beta-Glucans/administration & dosage , Avena/chemistry , Rats , Oxidative Stress/drug effects , Colonic Neoplasms/prevention & control , Anticarcinogenic Agents/pharmacology , Azoxymethane , Wnt Signaling Pathway/drug effects , Disease Models, Animal , Animal Feed , Colon/pathology , Colon/drug effects , Colon/metabolism , Colorectal Neoplasms/prevention & control , Antioxidants/pharmacology
10.
Int Immunopharmacol ; 132: 111985, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38603862

ABSTRACT

BACKGROUND: Bronchial asthma is a severe respiratory condition characterized by airway inflammation, remodeling, and oxidative stress. ß-Glucan (BG) is a polysaccharide found in fungal cell walls with powerful immunomodulatory properties. This study examined and clarified the mechanisms behind BG's ameliorativeactivitiesin an allergic asthma animal model. METHOD: BG was extracted from Chaga mushroom and characterized using FT-IR, UV-visible, zeta potential, and 1H NMR analysis. The mice were divided into five groups, including control, untreated asthmatic, dexamethasone (Dexa)-treated (1 mg/kg), and BG (30 and 100 mg/kg)-treated groups. RESULTS: BG treatment reduced nasal scratching behavior, airway-infiltrating inflammatory cells, and serum levels of IgE significantly. Additionally, BG attenuated oxidative stress biomarkers by lowering malonaldehyde (MDA) concentrations and increasing the levels of reduced glutathione (GSH), glutathione peroxidase (GPx), and catalase (CAT). Immunohistochemical and flow cytometric analyses have confirmed the suppressive effect of BG on the percentage of airway-infiltrating cytotoxic CD8+ T cells. CONCLUSION: The findings revealed the role of CD8+ T cells in the pathogenesis of asthma and the role of BG as a potential therapeutic agent for asthma management through the suppression of airway inflammation and oxidative stress.


Subject(s)
Asthma , CD8-Positive T-Lymphocytes , Mice, Inbred BALB C , Ovalbumin , Oxidative Stress , beta-Glucans , Animals , Oxidative Stress/drug effects , beta-Glucans/pharmacology , beta-Glucans/therapeutic use , beta-Glucans/chemistry , Asthma/drug therapy , Asthma/immunology , Asthma/chemically induced , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/drug effects , Ovalbumin/immunology , Mice , Disease Models, Animal , Immunoglobulin E/blood , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Lung/pathology , Lung/drug effects , Lung/immunology , Female , Anti-Asthmatic Agents/pharmacology , Anti-Asthmatic Agents/therapeutic use
11.
Mol Nutr Food Res ; 68(9): e2300829, 2024 May.
Article in English | MEDLINE | ID: mdl-38682734

ABSTRACT

Beta-glucans and arabinoxylans are known for their immunostimulatory properties. However, in vivo these have been documented almost exclusively following parenteral administration, underemphasizing oral intake. C57BL/6 mice are fed either a control diet or a diet supplemented with yeast-derived whole ß-glucan particle (yWGP) or with rice-derived arabinoxylan (rice bran-1) at a concentration of 1%, 2.5%, or 5% weight/weight (w/w) for 2 weeks. Thereafter, cells from blood, bone marrow, and spleen are collected for ex vivo stimulation with various microbial stimuli. Dietary intake of yWGP for 2 weeks at concentrations of 1% and 2.5% w/w increases ex vivo cytokine production in mouse blood and bone marrow, whereas 5% w/w yWGP shows no effect. In the spleen, cytokine production remains unaffected by yWGP. At a concentration of 1% w/w, rice bran-1 increases ex vivo cytokine production by whole blood, but 2.5% and 5% w/w cause inhibitory effects in bone marrow and spleen. This study demonstrates that dietary yWGP and rice bran-1 induce immune priming in mouse blood and bone marrow, with the strongest effects observed at 1% w/w. Future human trials should substantiate the efficacy of dietary ß-glucans and arabinoxylans to bolster host immunity, focusing on dose optimization.


Subject(s)
Immunity, Innate , Mice, Inbred C57BL , Oryza , Xylans , beta-Glucans , Animals , Xylans/pharmacology , beta-Glucans/pharmacology , beta-Glucans/administration & dosage , Oryza/chemistry , Immunity, Innate/drug effects , Mice , Spleen/drug effects , Spleen/immunology , Cytokines/metabolism , Male , Dose-Response Relationship, Drug , Dietary Fiber/pharmacology
12.
Int J Biol Macromol ; 267(Pt 1): 131162, 2024 May.
Article in English | MEDLINE | ID: mdl-38574931

ABSTRACT

We developed an efficient mixed-strain co-fermentation method to increase the yield of quinoa ß-glucan (Q+). Using a 1:1 mass ratio of highly active dry yeast and Streptococcus thermophilus, solid-to-liquid ratio of 1:12 (g/mL), inoculum size of 3.8 % (mass fraction), fermentation at 32 °C for 27 h, we achieved the highest ß-glucan yield of (11.13 ± 0.80)%, representing remarkable 100.18 % increase in yield compared to quinoa ß-glucan(Q-) extracted using hot water. The structure of Q+ and Q- were confirmed through Fourier Transform Infrared (FTIR) and Nuclear Magnetic Resonance (NMR) spectroscopies. Q+ contained 41.66 % ß-glucan, 3.93 % protein, 2.12 % uronic acid; Q- contained 37.21 % ß-glucan, 11.49 % protein, and 1.73 % uronic acid. The average molecular weight of Q+(75.37 kDa) was lower than that of Q- (94.47 kDa). Both Q+ and Q- promote RAW264.7 cell proliferation without displaying toxicity. They stimulate RAW264.7 cells through the NF-κB and MAPK signaling pathways, primarily inducing NO and pro-inflammatory cytokines by upregulating CD40 expression. Notably, Q+ exhibited stronger immunostimulatory activity compared to Q-. In summary, the fermentation enrichment method yields higher content of quinoa ß-glucan with increased purity and stronger immunostimulatory properties. Further study of its bioimmunological activity and structure-activity relationship may contribute to the development of new immunostimulants.


Subject(s)
Chenopodium quinoa , Fermentation , beta-Glucans , Chenopodium quinoa/chemistry , Mice , beta-Glucans/chemistry , beta-Glucans/pharmacology , beta-Glucans/isolation & purification , Animals , RAW 264.7 Cells , Adjuvants, Immunologic/pharmacology , Adjuvants, Immunologic/chemistry , Cell Proliferation/drug effects , Molecular Weight , Streptococcus thermophilus/chemistry
13.
Int J Biol Macromol ; 267(Pt 1): 131388, 2024 May.
Article in English | MEDLINE | ID: mdl-38608982

ABSTRACT

We developed a facile method for the fabrication of a biodegradable delivery system composed of two blocks: curdlan and curcumin. This was achieved by chemical functionalization of curdlan through tosylation, amination followed by complexation with curcumin. A comprehensive evaluation of structural characterization and component stability showed that cur-cum complex exhibited better anticancer properties with enhanced thermal properties. The cur-cum complex shows pH sensitive sustained release behaviour with higher release at acidic pH and kinetic data of drug release follows the Korsmeyer-Peppas model. The cur-cum complex has ability to block the proliferation of the MCF-7 cell line as revealed by MTT assay which showed increased toxicity of cur-cum complex against these cell lines. The results obtained from western blot analysis demonstrated that the co-administration of cur and cum effectively induced apoptosis in MCF-7 cells. This effect was observed by a considerable upregulation of the Bcl-2/Bax ratio, a decline in mRNA expression of LDHA, level of lactate and LDH activity. The results clearly depict the role of functionalized curdlan as efficient carrier for curcumin delivery with prolonged, sustained release and enhanced bioavailability, thereby improving the overall anticancer activity.


Subject(s)
Apoptosis , Breast Neoplasms , Curcumin , Drug Liberation , beta-Glucans , Curcumin/pharmacology , Curcumin/chemistry , Curcumin/administration & dosage , beta-Glucans/chemistry , beta-Glucans/pharmacology , Humans , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Breast Neoplasms/metabolism , MCF-7 Cells , Female , Apoptosis/drug effects , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Drug Carriers/chemistry , Drug Delivery Systems , Cell Proliferation/drug effects , Hydrogen-Ion Concentration
14.
Int J Biol Macromol ; 266(Pt 2): 131289, 2024 May.
Article in English | MEDLINE | ID: mdl-38570002

ABSTRACT

Intranasal vaccination offers crucial protection against influenza virus pandemics. However, antigens, especially subunit antigens, often fail to induce effective immune responses without the help of immune adjuvants. Our research has demonstrated that a polyelectrolyte complex, composed of curdlan sulfate/O-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (CS/O-HTCC), effectively triggers both mucosal and systemic immune responses when administrated intranasal. In this study, stable nanoparticles formed by curdlan-O-HTCC conjugate (CO NP) were prepared and characterized. Furthermore, the efficacy of CO NP was evaluated as a mucosal adjuvant in an intranasal influenza H1N1 subunit vaccine. The results revealed that CO NP exhibits uniform and spherical morphology, with a size of 190.53 ± 4.22 nm, and notably, it remains stable in PBS at 4 °C for up to 6 weeks. Biological evaluation demonstrated that CO NP stimulates the activation of antigen-presenting cells (APCs), including macrophages and dendritic cells (DCs), both in vitro and in vivo. Furthermore, intranasal administration of CO NP effectively elicits cellular and humoral immune responses, notably enhancing mucosal immunity. Thus, CO NP emerges as a promising mucosal adjuvant for influenza subunit vaccines.


Subject(s)
Adjuvants, Immunologic , Administration, Intranasal , Chitosan , Influenza A Virus, H1N1 Subtype , Influenza Vaccines , Nanoparticles , Vaccines, Subunit , beta-Glucans , Influenza A Virus, H1N1 Subtype/immunology , Chitosan/chemistry , Nanoparticles/chemistry , Influenza Vaccines/immunology , Influenza Vaccines/chemistry , Influenza Vaccines/administration & dosage , beta-Glucans/chemistry , beta-Glucans/pharmacology , beta-Glucans/administration & dosage , Animals , Adjuvants, Immunologic/pharmacology , Adjuvants, Immunologic/chemistry , Adjuvants, Immunologic/administration & dosage , Mice , Vaccines, Subunit/immunology , Vaccines, Subunit/administration & dosage , Immunity, Mucosal/drug effects , Mice, Inbred BALB C , Female , Dendritic Cells/immunology , Orthomyxoviridae Infections/prevention & control , Orthomyxoviridae Infections/immunology
15.
Int J Biol Macromol ; 269(Pt 2): 131884, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38685541

ABSTRACT

The importance of ß-glucan from S. cerevisiae in angiogenesis has not been well studied. We investigated whether ß-glucan induces angiogenesis through PI3K/Src and ERK1/2 signaling pathway in HUVECs. We identified that ß-glucan induced phosphorylation of PI3K, Src, Akt, eNOS, and ERK1/2. Subsequently, we found that this phosphorylation increased the viability of HUVECs. We also observed that stimulation of ß-glucan promoted the activity of MEF2 and MEF2-dependent pro-angiogenic genes, including EGR2, EGR3, KLF2, and KLF4. Additionally, the role of ß-glucan in angiogenesis was confirmed using in vitro and ex vivo experiments including cell migration, capillary-like tube formation and mouse aorta ring assays. To determine the effect of ß-glucan on the PI3K/Akt/eNOS and ERK1/2 signaling pathway, PI3K inhibitor wortmannin and ERK1/2 inhibitor SCH772984 were used. Through the Matrigel plug assay, we confirmed that ß-glucan significantly increased angiogenesis in vivo. Taken together, our study demonstrates that ß-glucan promotes angiogenesis via through PI3K and ERK1/2 signaling pathway.


Subject(s)
Human Umbilical Vein Endothelial Cells , Kruppel-Like Factor 4 , MAP Kinase Signaling System , Neovascularization, Physiologic , Phosphatidylinositol 3-Kinases , beta-Glucans , src-Family Kinases , beta-Glucans/pharmacology , Humans , Phosphatidylinositol 3-Kinases/metabolism , Animals , MAP Kinase Signaling System/drug effects , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Neovascularization, Physiologic/drug effects , Mice , src-Family Kinases/metabolism , Cell Movement/drug effects , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Phosphorylation/drug effects , Proto-Oncogene Proteins c-akt/metabolism , Nitric Oxide Synthase Type III/metabolism , Angiogenesis
16.
Int J Biol Macromol ; 267(Pt 1): 131579, 2024 May.
Article in English | MEDLINE | ID: mdl-38688789

ABSTRACT

In this study, the curdlan-polyphenol complexes were constructed by a pH-driven method. The interaction between curdlan and various hydrophobic polyphenols (curcumin, quercetin, and chlorogenic acid) was investigated. Curdlan could self-assemble into particles for loading polyphenols through hydrogen bonding and hydrophobic interactions. The three polyphenols were embedded in curdlan in an amorphous state. The curdlan-curcumin complex showed the lowest viscoelasticity but exhibited the highest curcumin loading ability (34.04 ± 1.73 mg/g). However, the curdlan-chlorogenic acid complex emerged the opposite trend, indicating that the loading capacity was associated with the hydrophobicity of polyphenols. The antioxidant activity of curdlan significantly increased after combining with polyphenols, which could be maintained during in vitro simulated gastrointestinal digestion. In particular, the curdlan-quercetin complex exhibited the highest antioxidant activity and short-chain fatty acid concentration, which could influence gut microbiota composition by promoting the proliferation of Prevotella and inhibiting the growth of Escherichia_Shigella. In conclusion, the curdlan-polyphenol complexes prepared by an alcohol-free pH-driven method could effectively enhance the gastrointestinal stability of polyphenols as well as increase the antioxidant and prebiotic activities of curdlan, which could be applied as a functional ingredient to improve gut health.


Subject(s)
Antioxidants , Polyphenols , Prebiotics , beta-Glucans , beta-Glucans/chemistry , beta-Glucans/pharmacology , Antioxidants/pharmacology , Antioxidants/chemistry , Hydrogen-Ion Concentration , Polyphenols/chemistry , Polyphenols/pharmacology , Gastrointestinal Microbiome/drug effects , Quercetin/chemistry , Quercetin/pharmacology , Chemical Phenomena
17.
Int J Biol Macromol ; 268(Pt 2): 131683, 2024 May.
Article in English | MEDLINE | ID: mdl-38649076

ABSTRACT

Polyphenols and dietary fibers in whole grains are important bioactive compounds to reduce risks for obesity. However, whether the combination of the two components exhibits a stronger anti-obesity effect remains unclear. Caffeic acid is a major phenolic acid in cereals, and arabinoxylan and ß-glucan are biological macromolecules with numerous health benefits. Here, we investigated the effect of caffeic acid combined with arabinoxylan or ß-glucan on glucose and lipid metabolism, gut microbiota, and metabolites in mice fed a high-fat diet (HFD). Caffeic acid combined with arabinoxylan or ß-glucan significantly reduced the body weight, blood glucose, and serum free fatty acid concentrations. Caffeic acid combined with ß-glucan effectively decreased serum total cholesterol levels and hepatic lipid accumulation, modulated oxidative and inflammatory stress, and improved gut barrier function. Compared with arabinoxylan, ß-glucan, and caffeic acid alone, caffeic acid combined with arabinoxylan or ß-glucan exhibited a better capacity to modulate gut microbiota, including increased microbial diversity, reduced Firmicutes/Bacteroidetes ratio, and increased abundance of beneficial bacteria such as Bifidobacterium. Furthermore, caffeic acid combined with ß-glucan reversed HFD-induced changes in microbiota-derived metabolites involving tryptophan, purine, and bile acid metabolism. Thus, caffeic acid and ß-glucan had a synergistic anti-obesity effect by regulating specific gut microbiota and metabolites.


Subject(s)
Caffeic Acids , Diet, High-Fat , Gastrointestinal Microbiome , Obesity , Xylans , beta-Glucans , Animals , Xylans/pharmacology , Gastrointestinal Microbiome/drug effects , beta-Glucans/pharmacology , Obesity/metabolism , Obesity/drug therapy , Caffeic Acids/pharmacology , Mice , Diet, High-Fat/adverse effects , Male , Mice, Inbred C57BL , Lipid Metabolism/drug effects
18.
Sci Rep ; 14(1): 8179, 2024 04 08.
Article in English | MEDLINE | ID: mdl-38589471

ABSTRACT

Breast cancer has been reported to correlate with the infiltration of tumor-associated macrophages (TAMs) or M2-like macrophages in tumor microenvironment (TME) that could promote breast cancer progression. In contrast, M1-like macrophages displayed anti-tumor activity toward cancer. This study was focused on Auricularia polytricha (AP), a cloud ear mushroom, which has been reported for anti-tumor activity and immunomodulation. AP extracts were screened on differentiated THP-1 macrophages (M0). Results demonstrated that water extract (APW) and crude polysaccharides (APW-CP) could upregulate M1-related genes and cytokines production (IL-6, IL-1 ß and TNF-α) significantly. Moreover, APW and APW-CP showed a high expression of CD86 (M1 marker) compared to M0. The NF-κB signaling pathway is crucial for pro-inflammatory gene regulation. The APW and APW-CP treatment showed the induction of the NF-κB pathway in a dose-dependent manner, which related to the ß-glucan content in the extracts. Furthermore, APW-CP polarized macrophages were investigated for anti-tumor activity on human breast cancer cells (MCF-7 and MDA-MB-231). Results showed that APW-CP could inhibit the invasion of breast cancer cells and induce apoptosis. Therefore, M1 macrophages polarized by APW-CP showed anti-tumor activity against the breast cancer cells and ß-glucan may be the potential M1-phenotype inducer.


Subject(s)
Auricularia , Breast Neoplasms , beta-Glucans , Humans , Female , Breast Neoplasms/pathology , NF-kappa B/metabolism , Macrophages/metabolism , Polysaccharides/pharmacology , Polysaccharides/metabolism , beta-Glucans/pharmacology , beta-Glucans/metabolism , Tumor Microenvironment
19.
Biol Pharm Bull ; 47(4): 840-847, 2024.
Article in English | MEDLINE | ID: mdl-38616114

ABSTRACT

Trastuzumab, an anti-HER2 monoclonal antibody, is the mainstay treatment for of HER2-positive breast cancer. However, trastuzumab resistance is often observed during treatment. Therefore, new therapeutic strategies are needed to enhance the clinical benefits of trastuzumab. Maitake ß-glucan MD-Fraction, isolated from Grifola frondosa, inhibits tumor growth by enhancing immune responses. In this study, we examined the effect of MD-Fraction on trastuzumab treatment of HER2-positive breast cancer. MD-Fraction did not directly inhibit the survival of HER2-positive breast cancer cells, alone or in the presence of trastuzumab in vitro. In HER2-positive xenograft models, the combination of MD-Fraction and trastuzumab was more effective than trastuzumab alone. Peripheral blood lymphocytes and splenic natural killer cells isolated from BALB/c nu/nu mice treated with MD-Fraction showed enhanced trastuzumab-induced antibody-dependent cellular cytotoxicity (ADCC) ex vivo. MD-Fraction-treated macrophages and neutrophils did not show enhanced trastuzumab cytotoxicity in the presence of heat-inactivated serum, but they showed enhanced cytotoxicity in the presence of native serum. These results suggest that MD-Fraction-treated macrophages and neutrophils enhance trastuzumab-induced complement-dependent cellular cytotoxicity (CDCC). Treatment of HER2-positive breast cancer cells with MD-Fraction in the presence of trastuzumab and native serum increased C3a release and tumor cell lysis in a dose-dependent manner, indicating that MD-Fraction enhanced trastuzumab-induced complement-dependent cytotoxicity (CDC) by activating the complement system. This study demonstrates that the combination of trastuzumab and MD-Fraction exerts a greater antitumor effect than trastuzumab alone by enhancing ADCC, CDCC, and CDC in HER2-positive breast cancer.


Subject(s)
Breast Neoplasms , Grifola , beta-Glucans , Animals , Mice , Humans , Female , Trastuzumab/pharmacology , Trastuzumab/therapeutic use , beta-Glucans/pharmacology , Antibody-Dependent Cell Cytotoxicity , Adjuvants, Immunologic , Breast Neoplasms/drug therapy , Mice, Inbred BALB C
20.
Biotech Histochem ; 99(2): 92-100, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38444353

ABSTRACT

We investigated the effects of ß-glucan (ßg) on kidney and liver damage caused by cisplatin (CP), an antineoplastic agent widely used to treat many types of cancer, in a rat model. The side effects of CP in many tissues and organs limit its usage. ßg is a natural polysaccharide that is an effective free radical scavenger. A total of 28 rats were randomly divided into four groups. Group 1 was a non-intervention control, only feed and water were given. Group 2 was administered 7 mg/kg CP in a single dose. Group 3 was administered 50 mg/kg ßg orally for 14 days. Group 4 was administered ßg for 14 days, following a single dose of CP. At the end of the experiment, kidney and liver tissues were evaluated biochemically and histopathologically. Increased thiobarbituric acid-reactive substances (TBARS) levels, as well as decreased catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx) activities, and reduced glutathione (GSH) levels, as well as histological damage, were noted in both the kidney and liver tissues of the CP group. However, ßg treatment prevented the oxidative and histopathological effects of CP. The study demonstrates the protective efficacy of ßg against CP-induced kidney and liver damage through the effect of its antioxidant properties.


Subject(s)
Cisplatin , beta-Glucans , Animals , Rats , Cisplatin/toxicity , Liver , Kidney , Antioxidants/pharmacology , beta-Glucans/pharmacology , Oxidative Stress
SELECTION OF CITATIONS
SEARCH DETAIL
...